Learning to Self-Care: a new approach to ease RA stiffness?
NCT ID NCT07761767
First seen Aug 12, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This trial tests whether a structured self-care education program can reduce joint stiffness and improve functional ability in people with rheumatoid arthritis. Participants are split into two groups: one receives the education program alongside usual care, while the other gets usual care alone. Joint stiffness and daily functioning are measured before and after the program. The goal is to see if teaching patients about joint protection, exercise, and energy conservation can make a real difference in their symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A self-care educational program teaching joint protection, physical activity, exercise, energy conservation, and symptom management, added to routine care.
- What this could lead to
- If effective, this program could offer a simple, low-cost way to help people with rheumatoid arthritis manage stiffness and stay active in daily life.
- What could go wrong
- This is a single-center trial with 110 participants, so results may not apply broadly. The program's success depends on patient adherence and may not change the underlying disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 110 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The criteria for selection were: patients" age ranged between 20-65 years old; did not have any auditory, visual or psychological problems. Patients who are able to communicate and participate in the educational program. Patients who agree to participate in the study. Exclusion Criteria: * Patients with severe cognitive or communication impairment. Patients with other severe musculoskeletal conditions that may affect functional ability. Patients who have participated in a similar self-care educational program recently.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Rheumatoid arthritis (RA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smartphone app aims to catch rheumatoid arthritis before it takes hold
- A patient questionnaire may rival lab tests for spotting rheumatoid arthritis flares
- Could fewer pills mean same relief for rheumatoid arthritis?
- Can a single cell therapy calm multiple autoimmune diseases?
- Heart risk in rheumatoid arthritis: could a blood vessel drug help?
- Can talk therapy plus exercise beat arthritis fatigue?